This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of TherapeuticsMD Inc. (TXMD) shed 2.15% to $1.82 Thursday, on what proved to be an all-around great trading session for the stock market, with the NASDAQ Composite Index rising 2.54% to 25,809.66 and the Dow Jones Industrial Average rising 1.86% to 50,848.75.
This was the stock's second consecutive day of losses.
TherapeuticsMD Inc. closed 38.31% below its 52-week high of $2.95, which the company achieved on January 27th.
The stock underperformed when compared to some of its competitors Thursday, as AbbVie Inc. (ABBV) fell 0.08% to $224.77.
Trading volume (53,712) eclipsed its 50-day average volume of 31,408.
Data source: Dow Jones Market Data, FactSet. Data compiled June 11, 2026.
This content was created by MarketWatch, which is operated by Dow Jones &amp; Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
06-11-26 1732ET

TXMD

TherapeuticsMD Inc. (TXMD) shares fell 2.15% to $1.82 on Thursday, underperforming the broader market and competitors like AbbVie despite a strong trading session for major indices. This marks the stock's second consecutive day of losses, with prices now 38.31% below its 52-week high. Trading volume exceeded its 50-day average.

TherapeuticsMD Inc. Stock Underperforms Thursday When Compared To Competitors